SG1A
Approved For Release 2003/09/10
: CIA-RDP96-00792R000200650009-6
CONFIDENTIAL
PAGE: 0003
COUNTRY:
(U)
CHINA
(CH).
SECTION
001
OF
004
/***********
THIS
IS
A COMBINED MESSAGE ************/
BODY
SUB J
:
LIBERATION ARMY
(U)
V QIGONG
RESEARCH
BY CHINA'S
PEOPLE'S
WARNING:
(U)
THIS
IS
AN INFORMATION REPORT,
NOT FINALLY EVALUATED
INTELLIGENCE
.
SGI
A
CONFIDENTIAL
Approved For Release 2003/09/10
: CIA-RDP96-00792R000200650009-6
SG1A
Approved For Release 2003/09/10
: CIA-RDP96-00792R000200650009-6
CONFIDENTIAL
DEPARTMENT
OF
DEFENSE
PAGE
s 0004
DOI:
(U)
910410.
REBS
s
SOURCE?
1.
(U)
JOURNAL,
DONGFANG QIGONG
(Dfi)
(ORIENTAL SCIENCE
QIGONG )
,
BEIJING,
CHINA,
NO.
3,
1990,
IN CHINESE.
2.
(U)
NEWSPAPER,
JINGJI
RIBAO
(JR),
BEIJING,
CHINA,
APRIL
1 99
,
IN CHINESE
.
3.
(U)
JOURNAL,
QIGONG
YU KEXUE
( BK )
( QIGONG
AND SCIENCE),
GUANGZHOU,
CHINA,
NOS.
3,
4,
AND
10,
1990;
NO.
4,
1991,
IN
CHINESE.
4.
(U)
JOURNAL,
QIGONG ZAZHI
(QZ)
( QIGONG
JOURNAL),
HANGZHOU,
CHINA,
VOL.
11,
NO.
4,
1990,
IN CHINESE.
5.
(U)
JOURNAL,
ZHONGGUO QIGONG
(ZB)
(CHINESE
BIGONG )
,
BINHUANGDAO,
CHINA,
NOS.
AND
5,
1990,
IN CHINESE.
it
(Gif
1J 2 0
NESE
OF
PHYS
GENERATING
THAT ENERGY
FIELD COMMENT —
IS
A CHINESE SYSTEM
r AND MENTAL EXERCISES PRACTICE^JITH
THE AIM
OF
NATURAL THERAPEUTIC
ENERGY. igggy IS
THE APPLICATION
OF
TO VARIOUS
PARTS
OF
THE BOD^^^A QIGONG PRACTITIONER
PURPOSES)
TO PRESERVED
A.
(U)
TITLE —
"EFFECT
OF WAIQI
WHEN APPLIED
BLOOD
IN VITRO"
(ZB,
NO.
2,
1990,
PP
.
-
12)
- RESEARCHERS —
((XU))
WUGE
(STC
1776
3527
2706),
((LU))
HUAIXIA
(STC
6424
2037
7209),
((LE))
SHULING
(STC
0519
3219
3781),
((WU))
YANGJING
(STC
2976
0111
2533),
((LI))
DAZHI
(STC
2621
1129
1807),
AND
((WAN))
SUJIAN
(STC
8001
5685
1696)
- AFFILIATIONS — BEIJING
MR GENERAL HOSPITAL MEDICAL
LABORATORY
AND
BEIJING
MR QIGONG
INSTITUTE
(FIELD
COMMENT —
SOURCE
DOES
NOT
INDICATE
THE
SIX
RESEARCHERS’
RESPECTIVE
ORGANIZATIONAL
AFFILIATIONS).
- CONTENTS — EXPERIMENTS
FOR THIS RESEARCH WERE CONDUCTED
DURING
JUNE
1988
AND MARCH
1989.
IN
THE
JUNE
1988 EXPERIMENTS,
WHEN WAIBI
WAS
APPLIED
TO
THE PRESERVED
IN VITRO
BLOOD
OF
THE
EXPERIMENTAL
GROUP,
THERE WAS
LESS DECLINE
IN
RED
BLOOD
CELLS
AND
HEMOCHROME
(FIELD
COMMENT —
A CHEMICAL COMPONENT
OF HEMOGLOBIN)
AS
COMPARED WITH
THE
CONTROL
GROUP.
IN ADDITION,
NO RETICULOCYTES
WERE
FORMED
IN
THE EXPERIMENTAL
GROUP.
IMPAIRMENT
OF LYMPHOCYTES
ALSO
DIFFERED MARKEDLY BETWEEN BOTH
GROUPS,
WITH
12.32
PERCENT
LYMPHOCYTE IMPAIRMENT
IN
THE EXPERIMENTAL
GROUP
AND
19.71
PERCENT
LYMPHOCYTE IMPAIRMENT
IN THE CONTROL
GROUP.
FURTHERMORE,
RED BLOOD
CELLS
AND SERUM SUPEROXIDE
DISMUTASE
(SOD)
LEVELS WERE
FOUND
TO
BE
CONFIDENTIAL
Approved For Release 2003/09/10
; CIA-RDP96-00792R000200650009-6
Approved For Relea^^^9/10 ^glA-RDP96-00792R000200650009-6
PAGE
= 0005
HIGHER
IN THE EXPERIMENTAL
GROUP.
IN
THE LATER TESTS,
DAMAGE
TO
LYMPHOCYTES DIFFERED WIDELY BETWEEN
THE
TWO
GROUPS,
WITH
3.7
PERCENT
LYMPHOCYTE DAMAGE
IN THE EXPERIMENTAL
GROUP,
AND
4.6
PERCENT LYMPHOCYTE
DAMAGE
IN
THE
CONTROL
GROUP.
B.
(U)
TITLE —
"BIOLOGICAL REACTION
OF COLON BACILLI
TO
wAiai"
(ze,
no.
2,
1990,
pp.
10,
12,
13)
- RESEARCHERS —
XU
WUGE,
((LIU))
WEILUN
(STC
0491
4850
0243),
((LIU))
YUCHI
(STC
0491
3768
3069),
LI
DAZHI,
AND WAN SUJIAN
- AFFILIATIONS
-- BEIJING
MR GENERAL HOSPITAL MEDICAL
LABORATORY,
AND
BEIJING
MR aiGONG INSTITUTE
(FIELD COMMENT —
SOURCE ERRONEOUSLY
CALLED
THIS
INSTITUTE
"THE
RESEARCH
AND CLINICAL
INSTITUTE").
(FIELD
COMMENT — RESPECTIVE ORGANIZATIONAL
AFFILIATIONS
OF
EACH RESEARCHER WERE NOT GIVEN IN SOURCE.)
- CONTENT — EXPERIMENTS WERE
CONDUCTED
IN JUNE
1988
AND MARCH
1989
IN WHICH WAiai
WAS FOUND
TO INHIBIT
THE
GROWTH
OF COLON
BACILLI.
IN THE
JUNE
1988
TESTS,
MAXIMUM GROWTH INHIBITION WAS
OBSERVED
FROM
THE
3D
HOUR
OF BACTERIAL GROWTH
THROUGH
THE
12TH
HOUR;
THAT
IS,
FROM THE ACTIVE PERIOD
OF
THE BACCHUS'
GROWTH
THROUGH
ITS
PERIOD
OF STABLE
GROWTH.
IN
THE MARCH
1989
TESTS,
THE
GROWTH
OF COLON BACILLUS
WAS
INHIBITED
UNTIL
THE
6TH
HOUR
OF
GROWTH,
THE
BACILLUS'
ACTIVE
GROWTH
PERIOD.
IN ADDITION,
DURING
THE
EXPERIMENT,
FUSION
OF MEMBRANES
AND
CELL WALLS
OF
TWO SEPARATE
CELLS
WAS
OBSERVED.
THE CHROMOMETER
USED
WAS
A
SERIES
1-2-3
(SIC)
MULTIPURPOSE BIOCHEMICAL
ANALYZER MADE
BY
THE
BAKER COMPANY,
A
UNITED STATES
FIRM.
C.
(U)
TITLE —
"FRE8UENCY SPECTROGRAM
OF QIGONG THERAPISTS
OBSERVED
USING
A LASER DEVICE
FOR MEASUREMENT
OF CAPILLARY BLOOD
FLOW"
(Za,
NO.
5,
1990,
PP
.
11-12)
- RESEARCHERS
AND AFFILIATION —
XU
WUGE
OF
THE BEIJING
MR
GENERAL HOSPITAL
AND
OTHERS.
-
CONTENT — CHANGES
IN VOLUME
OF
BLOOD FLOW
IN QIGONG
PRACTIONERS WERE MEASURED
AT
THE LAOGONG
XUEWEI
(STC
0525
1362
4494
0143)
(FIELD
COMMENT —
THIS REFERS
TO
A
POINT
BETWEEN
THE
SECOND
AND
THIRD METACARPAL
BONE,
WHICH
THE
TIP
OF
THE MIDDLE
FINGER
TOUCHES WHEN
THE
FIST
IS CLENCHED)
USING
A
LASER DEVICE DESIGNED
TO
MEASURE
CAPILLARY
BLOOD
FLOW.
THE DEVICE DISPLAYS
ITS MEASUREMENT
OF
THE VOLUME
OF
CAPILLARY
BLOOD
FLOW IN
VOLTS.
THE AVERAGE
PEAK
VOLTAGE MEASURED
IN QIGONG
PRACTIONERS
WAS
1,802 MILLIVOLTS,
BUT
THE
AVERAGE
PEAK VOLTAGE MEASURED
IN PERSONS
WITH
NO
TRAINING
IN
£I_GONG
WAS
40 MILLIVOLTS.
MOREOVER,
DIFFERENCES
IN VOLTAGE
VARIED
WITH
THE METHOD
AND STYLE
OF
QIGONG
USED
IN
THE
EXPERIMENTS.
THE
HIGHEST
VOLTAGES
WERE RECORDED
IN THOSE PERSONS
WHO
HAD
THE MOST
EXPERIENCE PRACTICING
QIGONG
.
ON AVERAGE,
PEAK VOLTAGE WAS
ACHIEVED
BY
QIGONG PRACTIONERS
4 MINUTES
AFTER THEY BEGAN
PERFORMING
QIGONG
.
IN NO
CASE
DID
IT
TAKE
A PRACTIONER LONGER THAN
8 MINUTES
TO REACH
PEAK
VOLTAGE.
D.
(U)
TITLE —
"EFFECT
OF
QIGONG
WAIBI
ON ELECTROPHORESIS
OF
RED
BLOOD
CELLS
IN PATIENTS"
(DQ,
NO.
3,
1990,
PP.
46-47)
- RESEARCHERS
AND AFFILIATION —
((FENG))
LIDA
(STC
7458
3810
6671),
((LI))
YUMIN
(STC
2621
3768
2404),
((CHEN))
HAIXIN
(STC 7115
3189
9515)
OF
THE
PLA NAVY
GENERAL
HOSPITAL,
SHANGHAI.
CONTENT —
QiaONG PRACTITIONERS APPLIED WAIQI RADIATION FOR
MINUTES
TO
IN
VITRO
BLOOD
SAMPLES TAKEN FROM
108
PATIENTS SUFFERING
CONFIDENTIAL
Approved For Release 2003/09/10
: CIA-RDP96-00792R000200650009-6
Approved For Relea^^^^^^lA-RDP96-00792R000200650009-6
PAGE
* 0006
FROM TUMORS,
DIABETES,
AND
ISCHEMIA.
THE ELECTROPHORETIC VELOCITY
OF
RED BLOOD
CELLS
INCREASED
UPON EXPOSURE
TO WAIQI
RADIATION.
IN
CASES,
THE ELECTROPHORETIC VELOCITY
OF
THE
RED
BLOOD
CELLS
BEGAN
TO
RISE
AT
THE BEGINNING
OF
THE EXPERIMENT.
ALTHOUGH
THE MECHANISM
OF
THE
ACTION
OF WAIQI
ON CELL ELECTROPHORESIS
IS
UNCLEAR,
WAIQI
HAS
PROVED EFFECTIVE
IN TREATING
TUMORS,
DIABETES,
AND ISCHEMIA.
WAIQI
HAS
BEEN FOUND
TO
BE PARTICULARLY
EFFECTIVE
IN TREATING
RED
BLOOD
CELLS
THAT
HAVE SLOWER ELECTROPHORETIC VELOCITIES.
E.
(U)
TITLE —
ACTION
OF QIGONG WAIQI
ON ARTIAL NATRIURETI
POLYPEPTIDE,
UREA NITRIDE,
AND CREATININE
IN DIALYSIS
PATIENTS
( QK
,
NO.
3,
1990,
PP.
21-22)
- RESEARCHERS
AND AFFILIATION —
C(WANG))
XIUQING
(STC
3769
4423
3237),
((LIU))
CUIHONG
(STC
0491
5050
4767),
((ZHAO))
YUNTAO
(STC
6392
0061
3447),
((ZHANG))
ZHAOFU
(STC
1728
2507
7450),
((ZHOU))
CHUNHUA
(STC
0719
2504
5478)
AND
((DONG))
BAO
(STC
5516
5508)
OF
THE
PLA NAVY GENERAL HOSPITAL'S
DEPARTMENT
OF
INTERNAL
NEPHROLOGY
- CONTENT —
TESTS WERE CONDUCTED
ON
PATIENTS WITH CHRONIC
UREMIA
RESULTING
FROM RENAL
FAILURE.
WHEN WAIQI THEREAPY WAS
ADMINISTERED
IN CONJUNCTION WITH CONVENTIONAL MEDICAL TREATMENT,
ARTIAL NATRIURETI
POLYPETIDE
AND
UREA NITRIDE LEVELS
IN
THE
PATIENTS'
BLOOD
PLASMAS
SHOWED MARKED REDUCTIONS,
AND PROSTAGLANDIN
LEVELS INCREASED.
HOWEVER,
CREATININE
AND THRONBOXANE LEVELS
SHOWED
LITTLE
CHANGE.
F.
(U)
TITLE
--
"EFFECT
OF
QIGONG WAIQI
ON PHAGOCYTOSIS
OF
IN
VITRO
HUMAN LEUCOCYTES"
( QK
,
NO.
4,
1991,
P.
18)
- RESEARCHERS
AND AFFILIATION —
FENG
LIDA,
((CHEN))
SHUYING
(STC
7115
3219
5391)
AND
((WANG))
YUNSHENG
(STC
3769
0061
3932)
OF
THE IMMUNOLOGY
CENTER,
PLA
NAVY GENERAL
HOSPITAL,
SHANGHAI
”
CONTENT —
GENERALLY,
APPLIED WAIQI RADIATION WAS
FOUND
TO
IMPROVE PHAGOCYTOTIC FUNCTION
OF
IN VITRO WHITE
BLOOD
CELLS.
IN
OF
THE
CASES
TESTED,
A
9.26
PERCENT IMPROVEMENT
IN PHAGOCYTOTIC
FUNCTION
OF
IN
VITRO
LEUCOCYTES WAS
NOTED.
IN
THE OTHER
CASES,
IMPAIRMENT
OF
IN VITRO
LEUCOCYTE PHYGOCYTOTIC FUNCTION WAS
RECORDED
G.
(U)
TITLE —
"EFFECT
OF
QIGONG
ON FUNCTION
OF
BLOOD
NEUTROPHILS
IN HUMANS"
(QZ,
VOL.
11,
NO.
4,
1990,
PP.
171-173)
- RESEARCHER
AND AFFILIATION —
((XIE))
ZHENCHUAN
(STC
6200
2182
1557)
OF
THE MEDICAL LABORATORY
AT
THE
CHENGDU
MR GENERAL
HOSPITAL,
CHENGDU
( GEOCOORD
: 30 40N/ 1 0 40 4E
)
- CONTENT — IMMUNOLOGIC FUNCTION
OF NEUTROPHILS
IN BLOOD
WAS
ENHANCED
AS
A
RESULT
OF
QIGONG
TRAINING.
THE PHAGOCYTOTIC
RATE
WAS
ABOUT
PERCENT
FOR THE EXPERIMENT'S CONTROL
GROUP,
BUT
THE
PHAGOCYTOTIC RATE
FOR
THE EXPERIMENTAL
GROUP,
WHICH
STOOD
AT
ABOUT
PERCENT
BEFORE
THE
EXPERIMENT,
ROSE
TO
ABOUT
38 PERCENT
ON THE
3 0 TH
DAY
OF
THE
SUBJECTS'
QIGONG
TRAINING.
THE EXPERIMENTAL
GROUP
ALSO EXPERIENCED
AN INCREASE
IN
ITS
RATE
OF POSITIVE
CELL REACTION
TO NITROBLUE TETRAZOLIUM TESTS,
WHICH
ROSE
FROM ABOUT
PERCENT
BEFORE
THE EXPERIMENT
TO
ABOUT
PERCENT
ON THE
30TH
DAY
OF
QIGONG
TRAINING.
THE CONTROL
GROUP
HAD
A
POSITIVE
CELL
REACTION
RATE
TO
NITROBLUE TETRAZOLIUM TESTS
OF
ABOUT
PERCENT.
H.
(U)
TITLE —
"EFFECT
OF
QIGONG
ON HEMODYNAMICS
AND
BLOOD
RHEOLOGY"
( QK
,
NO.
4,
1990,
P.
16)
CONFIDENTIAL
Approved For Release 2003/09/10
: CIA-RDP96-00792R000200650009-6
Approved For
^JIA-RDP96-00792R000200650009-6
PAGE
: 0007
- RESEARCHERS
AND AFFILIATION —
((WANG))
XIUFANG
(STC
3769
4923
5364)
AND
((LUO))
FENG
(STC
7482
6912),
OF
THE
PLA
AIR FORCE
HOSPITAL
IN LANZHOU
( GEOCOORD
: 36 03N/ 1 0 34
1 E
)
.
-
CONTENT — AFTER UNDERGOING
QIGONG
TRAINING,
SIGNIFICANT
REDUCTIONS WERE NOTED
IN THE FOLLOWING HEMODYNAMIC
AND
BLOOD
RHEOLOGY INDICATORS — TOTAL CARDIAC
OUTPUT,
HEART RATE
INDEX,
CARDIAC OUTPUT
PER MINUTE,
AVERAGE SYSTOLIC PRESSURE,
AVERAGE
DIASTOLIC PRESSURE,
AVERAGE ARTERIAL BLOOD
PRESSURE,
CARDIAC
INDEX,
EFFECTIVE
BLOOD
VOLUME,
AND
PULSE
RATE.
CONSPICUOUS INCREASES WERE
NOTED
IN CAPILLARY SEMI-RENEWAL
TIME
AND
AVERAGE’ RETENTION
TIME.
QIGONG WAS FOUND
TO INHIBIT
THE SYMPATHETIC NERVOUS
SYSTEM,
TO
RELAX
THE SKELETAL MUSCLES,
AND
INCREASE CAPILLARY
BLOOD
FLOW.
AS
A
RESULT
OF INCREASED
CAPILLARY’ BLOOD
FLOW,
MORE
OXYGEN,
NUTRIENTS,
AND
HORMONES REACH
CELLS.
I.
(U)
OTHER RESEARCH
BEIJING
MR &IGONG INSTITUTE
AND BEIJING
MR GENERAL HOSPITAL
CONDUCTED
JOINT RESEARCH
ON
( QIGONG
WITH
THE
PLA
ACADEMY
OF MILITARY
- RESEARCHERS
AND AFFILIATION
--
XU WUGE
OF
THE BEIJING
MR
GENERAL
HOSPITAL,
WAN SUJIAN
OF
THE
BEIJING
MR QIGONG INSTITUTE
AND
OTHERS.
-
CONTENT — TRADITIONALLY,
QIGONG
HAS BEEN USED WITH FAVORABLE
RESULTS
IN CHINA
TO TREAT TRAUMATIC PARAPLEGIA.
THIS STUDY WAS
LAUNCHED
IN EARLY
1990
TO DETERMINE THE EFFECTS
OF SHORT-TERM
TREATMENT
ON
ACUTE
CASES
OF SPINAL CORD INJURY
AND CHANGES INDUCED
BY
SUCH TREATMENT
IN SPINAL
CAPILLARY
CIRCULATION.
IN
THE
EXPERIMENT,
DOGS WERE
USED
AS
SUBJECTS.
QIGONG
WAS
FOUND
TO
BE
EFFECTIVE
IN RESTORING NERVE
FUNCTION AND SPINAL CAPILLARY
CIRCULATION,
IN HELPING
THE
DOGS
REGAIN LOST WEIGHT,
AND
AS
A
SEDATIVE
IN CANINE
TRAUMATIC PARAPLEGIA
CASES.
B.
(U)
TITLE —
" QIGONG
TREATMENT
OF
CASES
OF FACIAL
PARALYSIS
OF
THE PERIPHERAL NERVES"
( QK
,
NO.
10,
1990,
P.
25).
RESEARCHERS
AND AFFILIATION —
((REN))
GUANGPING
(STC
0117
1639
1627)
,AND
((TANG))
CHENGPEI
(STC
0781
2110
1014)
OF
THE PHYSICAL
THERAPY LABORATORY,
261ST
PLA
HOSPITAL.
-
CONTENT —
THIS
TREATMENT WAS CONDUCTED BETWEEN JANUARY
1987
AND
OCTOBER
1989
USING
A
220
VOLT CURRENT
AND
THE APPLICATION
OF
WAIQI.
OF
THE
PATIENTS
TREATED,
COMPLETELY
RECOVERED,
SHOWED SIGNIFICANT IMPROVEMENT,
AND
SHOWED MODERATE IMPROVEMENT.
ONE
OF
THE
PATIENTS,
HOWEVER,
EXPERIENCED
NO CHANGE
IN CONDITION.
C.
(U)
TITLE —
"EXAMPLE
OF
A
CURE
FOR LONG-TERM DYSURIA
RESULTING
FROM TRAUMATIC SPINAL INJURY"
( QK
,
NO.
9,
1990,
P.
28)
- RESEARCHERS
AND AFFILIATION
((LIU))
RUITING
(STC
0491
3843
1656)
OF
THE CLINIC
OF
THE
PLA
AIR
FORCE,
JINAN MR GENERAL
HEADQUARTERS,
JINAN
( GEOCOORD
: 3 6 4 ON/ 1
1 7 0 0 E )
.
- CONTENT
--
TREATMENT COMBINED BIOLOGICAL HOLOGRAPHIC
ACUPUNCTURE
THERAPY
(STC
3932
3670
0356
1873
6859
0459
4070
3127)
WITH
THE
APPLICATION
OF WAIQI.
WAIQI
WAS
APPLIED
FOR
10-20 MINUTES
TO
THE LAOGONG XUEWEI
AND
ABDOMEN
OF
THE
PATIENT,
A
6-YEAR-OLD
CONFIDENTIAL
Approved For Release 2003/09/10
: CIA-RDP96-00792R000200650009-6
Approved For Releag^^l^q. j£IA-RDP96-00792R000200650009-6
PAGE
: 0008
GIRL.
REMOTE WAIQI WAS
APPLIED
THE NEXT
DAY
AS WELL.
FOLLOWING
THE
TREATMENT,
THE PATIENT
WAS
ABLE
TO
ELIMINATE
300-500
MILLILITERS
OF
URINE
EVERY
2-3
HOURS
UNASSISTED WITH
NO RESIDUAL
URINE
.
D.
(U)
TITLE
--
"TREATMENT
OF STRESS HEADACHE WITH QIGONG "
(ZQ,
NO.
5,
1990,
PP.
15-16)
- RESEARCHERS
AND AFFILIATION —
((GAO))
ZHENGJIN
(STC
7559
2973
0093),
((LIU)
GUANGYOU
(STC
0491
0342
0645),
AND
((MING))
DEJUN
(STC
2494
1795
0193)
OF
THE
324TH
PLA
HOSPITAL,
CHONGQING
(GEOCOORD: 2 9 34N/ 1 0 6 35E )
.
-
CONTENT —
THE
CLINIC TREATED
THE
STRESS HEADACHE
PATIENTS
OF
THE EXPERIMENTAL
GROUP WITH
QIGONG
AND
THE
PATIENTS
OF
THE
CONTROL
GROUP WITH WESTERN MEDICINE.
THOSE
IN
THE
EXPERIMENTAL GROUP
HAD WAIQI APPLIED
DIRECTLY
TO
THE
AFFECTED
AREAS.
AFTER
THE WAIQI
TREATMENT,
PATIENTS WERE
GIVEN MASSAGE
THERAPY.
THE
CONTROL GROUP
WAS GIVEN PAIN KILLERS,
SEDATIVES,
SLEEPING
PILLS,
AND
VITAMIN
B
TABLETS.
AFTER TEN DAYS
OF
TREATMENT,
THE EXPERIMENTAL
GROUP
REPORTED
CASES
OF COMPLETE
CURE,
CASES
OF MARKED
IMPROVEMENT,
CASES
OF MODERATE
IMPROVEMENT,
AND
CASE
IN WHICH
THERE
WAS
NO
CHANGE.
THE CONTROL
GROUP REPORTED
CASES
OF
COMPLETE
CURE,
CASES
OF MARKED
IMPROVEMENT,
CASES
OF MODERATE
IMPROVEMENT,
AND
CASES
OF
NO
CHANGE
4.
(U)jggMA
fHERAPY
EQUIPMENT
A.
(U)
MODEL
F2-A MULTIFUNCTIONAL
QIGONG
THERAPY EQUIPMENT
(JR,
APRIL
1991,
P.
3)
THIS
EQUIPMENT
WAS DEVELOPED
AND MANUFACTURED
BY
THE JOINT
CHINA TIANHENG INTERNATIONAL ECONOMIC
AND TECHNOLOGY
TRADE COMPANY
(STC
0022
0948
1131
5899
0948
7139
4842
3444
2111
5890
6319
2496
0678
0155
4920
0361
0674)
(FIELD
COMMENT —
LOCATION UNKNOWN)
UNDER
THE SUPERVISION
OF
THE BEIJING
MR GENERAL
HOSPITAL.
THE EQUIPMENT
PROBABLY WILL
BE MARKETED
COMMERCIALLY
AFTER
THE MANUFACTURER
OBTAINS
PATENT RIGHTS
TO
THE EQUIPMENT.
THE EQUIPMENT
IS
DESIGNED
TO GENERATE WAIQI
THAT
WILL
FREE
CLOGGED
ENERGY
CHANNELS,
REDUCE
INFLAMMATION,
AND RELIEVE
PAIN.
THE
EQUIPMENT
IS
ALSO
DESIGNED
TO
FINE
TUNE
THE
AUTONOMIC NERVOUS SYSTEM
AND
THE IMMUNE
SYSTEM.
IT
IS ESPECIALLY
EFFECTIVE
IN TREATING
ANGIITIS,
TUMORS,
AND
PSEUDOMYOPIA.
IT
CAN ALSO
BE
USED
TO
TREAT
100
TYPES
OF
DISEASES,
INCLUDING ARTHRITIS,
HYPERTENSION,
DIABETES,
AND
BRONCHITIS.
IT
WAS CLINICALLY
FOUND
TO
BE
EFFECTIVE
IN
96.6
PERCENT
OF
THE CASES
TREATED
.
COMMENTS:
(FIELD
COMMENTS) — 1.
(U)
BASED
ON
THE NUMBER
OF
RESEARCH
PROJECTS
REPORTED,
THE BEIJING MR GENERAL
HOSPITAL,
THE
BEIJING
MR QIGONG
INSTITUTE,
AND
THE
PLA NAVY
GENERAL
HOSPITAL
APPEAR
TO
BE
THE PRIMARY
PLA ORGANIZATIONS INVOLVED
IN QIGONG
RESEARCH.
THE
LEADING RESEARCHERS
AT THESE ORGANIZATIONS
APPEAR
TO
BE
XU WUGE
OF
THE BEIJING
MR GENERAL
HOSPITAL,
WAN SUJIAN
OF
THE
BEIJING
MR QIGONG
INSTITUTE,
AND
FENG
LIDA
OF
THE
PLA NAVY GENERAL
HOSPITAL
.
2.
(U)
WITH
THE EXCLUSION
OF PARAGRAPH
3-1,
THE
EIGHT STUDIES
PERTAINING
TO
THE QIGONG MECHANISM CAN
BE BROKEN DOWN
AS FOLLOWS —
1)
SIX
STUDIES
RELATED
TO
QIGONG WAIQI,
THREE
OF WHICH CONCERN
THE
IN VITRO EFFECTS
OF WAIQI
RADIATION
(PARA
2-A,
2-D,
2-F),
TWO
CONFIDENTIAL
Approved For Release 2003/09/10
: CIA-RDP96-00792R000200650009-6